CIK 0001759138 · Non-accelerated filer<br>Smaller reporting company
Cabaletta Bio, Inc.
Sign in to watch- Ticker
- CABA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- Phone
- (267) 759-3100
- Business address
- 2929 ARCH STREET, SUITE 600, PHILADELPHIA, PA, 19104
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2025-05-19 | Nichtberger Steven President & CEO | Grant or award · Stock Option (Right to Buy) | +411,600 | 411,600 | ||
| 2025-05-19 | Nichtberger Steven President & CEO | Returned to the company · Stock Option (Right to Buy) | −353,000 | 0 | ||
| 2025-05-19 | Nichtberger Steven President & CEO | Grant or award · Stock Option (Right to Buy) | +353,000 | 353,000 | ||
| 2025-05-19 | Gerard Michael General Counsel | Returned to the company · Stock Option (Right to Buy) | −100,000 | 0 | ||
| 2025-05-19 | Gerard Michael General Counsel | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2025-05-19 | Gerard Michael General Counsel | Returned to the company · Stock Option (Right to Buy) | −75,000 | 0 | ||
| 2025-05-19 | Gerard Michael General Counsel | Grant or award · Stock Option (Right to Buy) | +75,000 | 75,000 | ||
| 2025-05-19 | Gerard Michael General Counsel | Returned to the company · Stock Option (Right to Buy) | −112,500 | 0 | ||
| 2025-05-19 | Gerard Michael General Counsel | Grant or award · Stock Option (Right to Buy) | +112,500 | 112,500 | ||
| 2025-05-19 | Gerard Michael General Counsel | Returned to the company · Stock Option (Right to Buy) | −100,000 | 0 | ||
| 2025-05-19 | Gerard Michael General Counsel | Grant or award · Stock Option (Right to Buy) | +100,000 | 100,000 | ||
| 2025-05-19 | HENRIQUES RICHARD C JR Director | Returned to the company · Stock Option (Right to Buy) | −46,428 | 0 | ||
| 2025-05-19 | HENRIQUES RICHARD C JR Director | Grant or award · Stock Option (Right to Buy) | +46,428 | 46,428 | ||
| 2025-05-19 | HENRIQUES RICHARD C JR Director | Returned to the company · Stock Option (Right to Buy) | −22,000 | 0 | ||
| 2025-05-19 | HENRIQUES RICHARD C JR Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-05-19 | HENRIQUES RICHARD C JR Director | Returned to the company · Stock Option (Right to Buy) | −22,000 | 0 | ||
| 2025-05-19 | HENRIQUES RICHARD C JR Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-05-19 | HENRIQUES RICHARD C JR Director | Returned to the company · Stock Option (Right to Buy) | −22,000 | 0 | ||
| 2025-05-19 | HENRIQUES RICHARD C JR Director | Grant or award · Stock Option (Right to Buy) | +22,000 | 22,000 | ||
| 2025-05-19 | Tomasello Shawn Director | Returned to the company · Stock Option (Right to Buy) | −44,000 | 0 |
Page 3 of 13 · 256 trades